美国精神药物市场规模、份额和趋势分析报告：按产品、形式、应用、分销管道和细分市场预测，2025 年至 2030 年

美国精神药物市场的成长与趋势

根据Grand View Research, Inc.的最新报告，美国精神药物市场预计到2030年将达到46.8亿美元，2025年至2030年期间的复合年增长率为9.0%。

这种强劲的成长主要是由于消费者对认知增强产品的认识和接受度不断提高。社会越来越关注在苛刻的专业和学术环境中的心理表现，加上日益增长的老龄人口担心认知能力下降，这些都极大地推动了需求。此外，精神活性药物的用途已不再仅仅增强认知功能，还包括情绪支持和减轻压力等领域，这扩大了市场吸引力并吸引了更多样化的消费者群体。

到 2024 年，天然产品将占很大比例。这是因为消费者偏好温和、安全的健康和保健解决方案。这种偏好很大程度上受到「天然」与更少的合成化学物质以及潜在的更轻微的副作用的联繫的影响。天然精神活性药物的有效行销和品牌推广进一步提升了它们的市场主导地位，利用了更广泛的「洁净标示」和植物来源趋势，这些趋势引起了注重健康的消费者的强烈共鸣，他们寻求符合自然、整体健康理念的认知增强解决方案。

预计能量饮料将在 2024 年占据最大的市场份额。这是因为能量饮料对消费者来说具有固有的便利性和可用性。即饮精神饮料可以无缝融入日常生活，并且比胶囊或粉末更容易饮用。此外，饮料通常具有快速吸收和快速起效的印象，符合许多精神药物使用者所期望的即时认知增强效果。这种饮料形式还允许在风味特征和味道遮罩方面具有更大的灵活性，从而增强偏好并吸引更广泛的消费者群体。

到 2024 年，认知增强将占据美国精神药物产业的最大份额。这一增长将解决这些材料的核心和最广为人知的用途。根本动力在于社会越来越重视在生活的许多领域中（从要求专业到竞争激烈的学术追求）的最佳心理表现。人们正在积极寻求解决方案来提高他们的注意力、记忆力、注意力和学习能力，以获得竞争优势并提高生产力。

主要市场参与企业包括利洁时集团 (Schiff RB Health (美国 ) LLC)、联合利华 Onnit Labs, Inc.、安丽、GNC Holdings, LLC、NeuroGum, Inc.、Qualia Life Sciences, LLC、NOW Foods.、Performance Lab USA Corp.、Natural Stacks、BrainMD Health 和 Nootropic Depot。这些公司正在采取各种措施来增加市场占有率，包括推出新产品、伙伴关係、併购和全球扩张。

美国精神药物市场报告重点

• 按产品划分，预计合成部分在预测期内将以显着的复合年增长率成长。其有针对性的认知增强能力和精确的配方正在刺激成长。持续的研究和开发使得开发具有特异性作用机制和比天然萃取物更强效力的新型合成化合物成为可能。生产合成化合物可以更好地控制纯度和一致性，从而可能产生更可预测和可靠的效果，从而吸引寻求优化、自订认知效果的用户。
• 根据形式，由于其有吸引力且方便的形式，预计软糖在预测期内将以显着的复合年增长率增长。软糖易于食用，提供有趣的消费体验，遮罩成分的潜在苦味，并模仿流行糖果甜点的味道。
• 根据应用，睡眠优化部分预计在预测期内以更快的复合年增长率增长。人们越来越意识到睡眠在认知功能和整体健康中的重要作用，以及睡眠障碍和压力相关睡眠问题的发生率不断增加，推动了对天然睡眠辅助剂的需求。
• 根据分销管道，由于可访问性和便利性的提高，预计预测期内线上部分将以更快的复合年增长率增长。与实体店相比，网路商店提供更广泛的精神活性药物选择，并且由于管理费用降低，通常提供有竞争力的价格。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国精神药物市场变数、趋势与范围

• 市场体系展望
• 产业价值链分析
  • 原料展望
  • 製造业和技术展望
  • 利润率分析
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
  • 市场机会
  • 市场问题
• 产业分析—波特五力分析
• 打入市场策略

第四章美国精神药物市场：产品、估计与趋势分析

• 美国精神药物市场（按产品划分）：关键要点
• 2024 年及 2030 年产品趋势分析及市场占有率
• 按产品，2018-2030
  • 自然的
  • 合成

第五章美国精神药物市场形式、估计与趋势分析

• 美国精神药物市场（按剂型划分）：关键要点
• 2024年和2030年的形态变化分析和市场占有率
• 按格式，2018-2030
  • 胶囊/锭剂
  • 粉末
  • 喝
  • 软糖
  • 其他（液体、贴片、新型给药方式）

第六章美国精神药物市场：按应用的估计和趋势分析

• 美国精神药物市场（按应用）关键要点
• 2024年及2030年应用变化分析及市场占有率
• 按应用，2018-2030 年
  • 提升认知能力
  • 情绪和压力管理
  • 睡眠优化
  • 能量和身体表现
  • 其他（微循环、抗衰长寿、改善社交焦虑及自信心、增强创造力）

第七章美国精神药物市场：按分销管道分類的估计和趋势分析

• 美国精神药物市场分销管道分析：关键要点
• 2024年及2030年通路变化分析及市场占有率
• 按格式，2018-2030
  • 离线
  • 在线的

第八章 竞争分析

• 主要市场参与企业的近期趋势和影响分析
• 公司分类
• 参与企业概况
• 2024年公司市场占有率分析（%）
• 公司热图分析
• 战略地图
• 公司简介
  • Qualia Life Sciences, LLC
  • Unilever（Onnit Labs, Inc.）
  • GNC Holdings, LLC
  • Performance Lab USA Corp.
  • NeuroGum, Inc.
  • Natural Stacks
  • Nootropics Depot
  • BrainMD Health
  • Reckitt Benckiser Group PLC（Schiff RB Health（US）LLC）
  • NOW Foods.

U.S. Nootropics Market Growth & Trends:

The U.S. nootropics market size is estimated to reach USD 4.68 billion in 2030, growing at a CAGR of 9.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. This robust expansion is primarily fueled by the increasing consumer awareness and acceptance of cognitive enhancement products. Heightened societal focus on mental performance in demanding professional and academic environments, coupled with a growing aging population concerned about cognitive decline, significantly boosts demand. Furthermore, the expanding application of nootropics beyond just cognitive enhancement, encompassing areas like mood support and stress reduction, broadens their market appeal and attracts a more diverse consumer base.

Natural products held a major share in 2024. This is due to consumer preferences for health and wellness solutions perceived as gentle and safe. This preference is strongly influenced by the association of "natural" with fewer synthetic chemicals and potentially milder side effects. The effective marketing and branding of natural nootropics, capitalizing on the broader 'clean label' and plant-based trends, further propelled their market dominance by resonating strongly with health-conscious consumers seeking cognitive enhancement solutions aligned with natural and holistic wellness philosophies.

The drinks segment held the largest share in 2024.This can be attributed to their inherent convenience and accessibility for consumers. Ready-to-drink nootropic beverages seamlessly integrate into daily routines, offering an easily consumable format compared to capsules or powders. Furthermore, drinks often provide a perception of faster absorption and quicker onset of effects, aligning with the immediate cognitive enhancement sought by many nootropic users. The beverage format also allows for greater flexibility in flavor profiles and taste masking, enhancing palatability and broadening appeal to a wider consumer base.

Cognitive enhance held the largest share in the U.S. nootropics industry in 2024. The growth addresses the core and most widely recognized application of these substances. The fundamental driver is the increasing societal emphasis on optimal mental performance in various aspects of life, from demanding professional careers to competitive academic pursuits. Individuals are actively seeking solutions to improve focus, memory, attention span, and learning capabilities to gain a competitive edge and enhance productivity.

Major market players include Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC); Unilever Onnit Labs, Inc.; Amway; GNC Holdings, LLC; NeuroGum, Inc.; Qualia Life Sciences, LLC; NOW Foods.; Performance Lab USA Corp.; Natural Stacks; BrainMD Health; and Nootropics Depot. Various steps are adopted by these companies, including new product launches, partnerships, mergers & acquisitions, global expansion, and others to gain more share of the market.

U.S. Nootropics Market Report Highlights:

• Based on product, the synthetic segment is estimated to grow at a substantial CAGR over the forecast period. The capacity for targeted cognitive enhancement and precise formulations have stimulated the growth. Ongoing research enables the development of novel synthetic compounds with specific mechanisms of action and enhanced potency compared to natural extracts. Synthetic production allows for greater control over purity and consistency, potentially leading to more predictable and reliable effects, appealing to users seeking optimized and tailored cognitive benefits.
• Based on form, the gummies segment is anticipated to grow at a significant CAGR over the forecast period, driven by the appealing and convenient format of gummies. Gummies offer a palatable and enjoyable consumption experience, masking the potential bitterness of ingredients and resembling popular confectionery.
• Based on application, the sleep optimization segment is anticipated to grow at a faster CAGR over the forecast period. The increasing recognition of sleep's crucial role in cognitive function and overall well-being and rising rates of sleep disorders and stress-induced sleep issues are driving demand for natural sleep aids.
• Based on distribution channel, the online segment is anticipated to grow at a faster CAGR over the forecast period due to enhanced accessibility and convenience. They offer a wider selection of nootropics compared to brick-and-mortar stores, often at competitive prices due to reduced overhead.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Product Outlook
• 2.3. Form Outlook
• 2.4. Application Outlook
• 2.5. Distribution Channel Outlook

Chapter 3. U.S. Nootropics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
• 3.2. Industry Value Chain Analysis
  • 3.2.1. Raw Material Outlook
  • 3.2.2. Manufacturing & Technology Outlook
  • 3.2.3. Profit Margin Analysis
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
  • 3.3.2. Market Restraint Analysis
  • 3.3.3. Market Opportunities
  • 3.3.4. Market Challenges
• 3.4. Industry Analysis - Porter's Five Forces Analysis
• 3.5. Market Entry Strategies

Chapter 4. U.S. Nootropics Market: Product Estimates & Trend Analysis

• 4.1. U.S. Nootropics Market, By Product: Key Takeaways
• 4.2. Product Movement Analysis & Market Share, 2024 & 2030
• 4.3. Market Estimates & Forecasts, by Product, 2018 - 2030 (USD Million)
  • 4.3.1. Natural
    • 4.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.3.2. Synthetic
    • 4.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. U.S. Nootropics Market: Form Estimates & Trend Analysis

• 5.1. U.S. Nootropics Market, By Form: Key Takeaways
• 5.2. Form Movement Analysis & Market Share, 2024 & 2030
• 5.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
  • 5.3.1. Capsules/Tablets
    • 5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3.2. Powder
    • 5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3.3. Drinks
    • 5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3.4. Gummies
    • 5.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3.5. Others (Liquid, patches, and novel delivery methods)
    • 5.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. U.S. Nootropics Market: Application Estimates & Trend Analysis

• 6.1. U.S. Nootropics Market, By Application: Key Takeaways
• 6.2. Application Movement Analysis & Market Share, 2024 & 2030
• 6.3. Market Estimates & Forecasts, by Application, 2018 - 2030 (USD Million)
  • 6.3.1. Cognitive Enhance
    • 6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.2. Mood & Stress Management
    • 6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.3. Sleep Optimization
    • 6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.4. Energy & Physical Performance
    • 6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.5. Others (Microcirculation, Anti-Aging & Longevity, Social Anxiety & Confidence Enhancement, Creativity boosting)
    • 6.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. U.S. Nootropics Market: Distribution Channel Estimates & Trend Analysis

• 7.1. U.S. Nootropics Market, By Distribution Channel: Key Takeaways
• 7.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
• 7.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
  • 7.3.1. Offline
    • 7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3.2. Online
    • 7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Analysis

• 8.1. Recent developments & impact analysis, by key market participants
• 8.2. Company Categorization
• 8.3. Participant's Overview
• 8.4. Financial Performance
• 8.5. Product Benchmarking
• 8.6. Company Market Share Analysis, 2024 (%)
• 8.7. Company Heat Map Analysis
• 8.8. Strategy Mapping
• 8.9. Company Profiles
  • 8.9.1. Qualia Life Sciences, LLC
    • 8.9.1.1. Company Overview
    • 8.9.1.2. Financial Performance
    • 8.9.1.3. Product Portfolios
    • 8.9.1.4. Strategic Initiatives
  • 8.9.2. Unilever (Onnit Labs, Inc.)
    • 8.9.2.1. Company Overview
    • 8.9.2.2. Financial Performance
    • 8.9.2.3. Product Portfolios
    • 8.9.2.4. Strategic Initiatives
  • 8.9.3. GNC Holdings, LLC
    • 8.9.3.1. Company Overview
    • 8.9.3.2. Financial Performance
    • 8.9.3.3. Product Portfolios
    • 8.9.3.4. Strategic Initiatives
  • 8.9.4. Performance Lab USA Corp.
    • 8.9.4.1. Company Overview
    • 8.9.4.2. Financial Performance
    • 8.9.4.3. Product Portfolios
    • 8.9.4.4. Strategic Initiatives
  • 8.9.5. NeuroGum, Inc.
    • 8.9.5.1. Company Overview
    • 8.9.5.2. Financial Performance
    • 8.9.5.3. Product Portfolios
    • 8.9.5.4. Strategic Initiatives
  • 8.9.6. Natural Stacks
    • 8.9.6.1. Company Overview
    • 8.9.6.2. Financial Performance
    • 8.9.6.3. Product Portfolios
    • 8.9.6.4. Strategic Initiatives
  • 8.9.7. Nootropics Depot
    • 8.9.7.1. Company Overview
    • 8.9.7.2. Financial Performance
    • 8.9.7.3. Product Portfolios
    • 8.9.7.4. Strategic Initiatives
  • 8.9.8. BrainMD Health
    • 8.9.8.1. Company Overview
    • 8.9.8.2. Financial Performance
    • 8.9.8.3. Product Portfolios
    • 8.9.8.4. Strategic Initiatives
  • 8.9.9. Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC)
    • 8.9.9.1. Company Overview
    • 8.9.9.2. Financial Performance
    • 8.9.9.3. Product Portfolios
    • 8.9.9.4. Strategic Initiatives
  • 8.9.10. NOW Foods.
    • 8.9.10.1. Company Overview
    • 8.9.10.2. Financial Performance
    • 8.9.10.3. Product Portfolios
    • 8.9.10.4. Strategic Initiatives

List of Tables

• Table 1 U.S. nootropics market - Key market driver analysis
• Table 2 U.S. nootropics market - Key market restraint analysis
• Table 3 U.S. nootropics market estimates & forecast, by product (USD Million)
• Table 4 U.S. Natural nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Table 5 U.S. Synthetic nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Table 6 U.S. Nootropics market estimates & forecast, by form (USD Million)
• Table 7 U.S. Capsules/Tablets nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Table 8 U.S. Powder nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Table 9 U.S. Drinks nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Table 10 U.S. Gummies nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Table 11 U.S. Other nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Table 12 U.S Nootropics market estimates & forecast, by application (USD Million)
• Table 13 U.S. Cognitive Enhance nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Table 14 U.S. Mood & Stress Management nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Table 15 U.S. Sleep Optimization nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Table 16 U.S. Energy & Physical Performance nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Table 17 U.S. others market estimates and forecast, 2018 - 2030 (USD Million)
• Table 18 U.S. nootropics market estimates & forecast, by distribution channel (USD Million)
• Table 19 U.S. Online nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Table 20 U.S. Offline nootropics market estimates and forecast, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 U.S. Noottopics market snapshot
• Fig. 2 U.S. Nootropics market segmentation & scope
• Fig. 3 U.S. Nootropics market penetration & growth prospect mapping
• Fig. 4 U.S. Nootropics market value chain analysis
• Fig. 5 U.S. Nootropics market dynamics
• Fig. 6 U.S. Nootropics market Porter's Five Forces analysis
• Fig. 7 U.S. Nootropics market: Product movement analysis, 2024 & 2030 (%)
• Fig. 8 U.S. Natural nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 9 U.S. Synthetic nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 10 U.S. Nootropics market: Form movement analysis, 2024 & 2030 (%)
• Fig. 11 U.S. Capsules/Tablets nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 12 U.S. Powder nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 13 U.S. Drinks nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 14 U.S. Gummies nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 U.S. Other nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 16 U.S. Nootropics market: Application movement analysis, 2024 & 2030 (%)
• Fig. 17 U.S. Nootropics market estimates and forecast for cognitive enhance, 2018 - 2030 (USD Million)
• Fig. 18 U.S. Nootropics market estimates and forecast for mood & stress management, 2018 - 2030 (USD Million)
• Fig. 19 U.S. Nootropics market estimates and forecast for sleep optimization, 2018 - 2030 (USD Million)
• Fig. 20 U.S. Nootropics market estimates and forecast for energy & physical performance, 2018 - 2030 (USD Million)
• Fig. 21 U.S. Nootropics market estimates and forecast for others, 2018 - 2030 (USD Million)
• Fig. 22 U.S. Nootropics market: Distribution channel movement analysis, 2024 & 2030 (%)
• Fig. 23 U.S. Online nootropics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 U.S. Offline nootropics market estimates and forecast, 2018 - 2030 (USD Million)